Drugs / sodium sulfate/potassium sulfate/magnesium sulfate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02523911 Comparator | Mar 2016 → Dec 2017 | colorectal cancer | MercyOne Des Moines Medical Center | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | sodium sulfate/potassium sulfate/magnesium sulfate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02523911 ↗ |
| Route | Oral | “Early in the evening prior to colonoscopy, patients will be instructed to consume one 6 ounce bottle of oral sodium sulfate/potassium sulfate/magnesium sulfate (Suprep) solution” NCT02523911 ↗ |